Compound Transfer Program

Pfizer has an extensive program of compound and pure substance supply for research purposes that encompasses all of our publicly known compounds. We review each request regarding use of our compounds for content, value, and consistency with Pfizer's direction for the requested compound.

We routinely enter Compound Transfer Agreements (CTAs) that provide the compound free of charge to a third party to conduct the agreed upon study. We require a manuscript or report of the conclusions to bring closure to the study. Pfizer reserves the right to deny any request that we feel does not advance our compound(s) or add value to human or animal health.

If you are interested in requesting a Pfizer pure compound please contact:

Maureen Surian
IIR Coordinator
Phone: +61 2 9850 3740
Email: Maureen.Surian@pfizer.com

Additional information can be located on the Pfizer Global website: www.pfizer.com/ctp